1 Articles

Tags :Ant Afu

AGIBOT, Ant Afu deploy smart triage robot at Peking University People's Hospital

The smart triage project jointly developed by AGIBOT and Ant Afu has been deployed at Peking University People’s Hospital, with Lingxi X2 serving as a “silicon-based receptionist” in outpatient services. The robot can provide patients and visitors with department guidance, consultation process information, answers to medical insurance policy questions and on-site navigation. By connecting to the hospital’s private knowledge base, Lingxi X2 can also deliver standardized medical guidance based on in-hospital information. Over 66 working days, it completed more than 46,000 interactions, averaging about 707 per day.

Briefs

Briefs

  • China's Youibot clears CSRC filing for Hong Kong IPO, eyes first mobile-manipulation robot listing

    China's securities regulator on Oct. 16 published a filing notice for Hefei Youibot Robotics Co., Ltd.'s overseas listing and full circulation of domestic unlisted shares, clearing a precondition for a Hong Kong Stock Exchange hearing and putting the company on track to become the first listed mobile-manipulation robot maker. Youibot plans to issue no more than 49,477,800 overseas-listed ordinary shares and list on the Hong Kong Stock Exchange, according to the notice. Thirty-seven shareholders plan to convert a combined 243,804,260 domestic unlisted shares into overseas-listed shares, achieving "full circulation."

  • AGIBOT, Ant Afu deploy smart triage robot at Peking University People's Hospital

    The smart triage project jointly developed by AGIBOT and Ant Afu has been deployed at Peking University People's Hospital, with Lingxi X2 serving as a "silicon-based receptionist" in outpatient services. The robot can provide patients and visitors with department guidance, consultation process information, answers to medical insurance policy questions and on-site navigation. By connecting to the hospital's private knowledge base, Lingxi X2 can also deliver standardized medical guidance based on in-hospital information. Over 66 working days, it completed more than 46,000 interactions, averaging about 707 per day.

  • Suzhou collaborative robot maker Fa'ao raises nearly 1 bln yuan in C+, D rounds

    Suzhou-based collaborative robot maker Fa'ao Robotics said it has completed C+ and D funding rounds, raising nearly 1 billion yuan ($140 million) in total. Meituan Longzhu led the C+ round and Meituan led the D round, the company said. Yongxin Capital, Shishan Phase II and Suzhou Venture Capital participated in the series, while existing shareholders Guolian Minsheng Capital, Suzhou Industrial Investment and Qingliu Capital increased their investments. Proceeds will mainly fund fixed-asset investment in core component capacity and expansion and R&D in industrial embodied intelligence, including its ART-series industrial humanoid force-controlled arms and AIRLab embodied intelligence tool platform.

  • Water smart hardware brand MIRAVA raises nearly 50 mln yuan in angel round

    MIRAVA, a water-surface smart consumer hardware brand under Shaanxi-based embodied intelligence company ORCAUBOAT, said it has raised nearly 50 million yuan in an angel round led by Jiuhe Venture Capital, with Chuxin Capital and Eversnow participating. The proceeds will mainly fund mass production of smart yacht products, first customer deliveries and European market expansion. MIRAVA focuses on the water consumer market and aims to integrate smart technology into water lifestyles. In September, it made its debut at the Cannes Yachting Festival, presenting its M800 to the European market for the first time.

  • Shenzhen ABROBOT raises tens of mln yuan in Series A+ round

    Shenzhen ABROBOT Medical Robot Co., Ltd. said it has raised tens of millions of yuan in a Series A+ funding round led by Puhe Capital, with Longgang Financial Holdings participating. Founded in June 2020 by Professor Guo Shuxiang, a foreign member of the Engineering Academy of Japan and an IEEE Fellow, and his team, ABROBOT focuses on the development and commercialization of vascular interventional surgical robots. Its products cover neurological, coronary, peripheral and oncological interventions. The company's first-generation PANVIS-A cerebrovascular interventional surgical assistance system received a Class III registration certificate from China's National Medical Products Administration in August 2024.

  • ACE Robotics, PetroChina Shanghai Sales unit partner on embodied AI convenience store pilot

    ACE Robotics and PetroChina Shanghai Sales Company have formed a strategic partnership to launch a pilot fully closed-loop embodied AI robot project in a gas station convenience store, the companies said.

    The partners will combine PetroChina Shanghai Sales' digital platform, supply chain system and offline convenience store network with ACE Robotics' capabilities in the Kaiwu world model, robot hardware and embodied intelligence technology. They aim to explore a four-in-one embodied retail co-creation model—"scenarios set the tasks, platforms coordinate, models drive, and robots execute"—and build a warehouse-store integrated smart retail paradigm for real business scenarios.

  • Jiangte Electric to invest 100 mln yuan in robot startup Vita Dynamics

    Jiangte Electric (002176.SZ) said it plans to invest 100 million yuan alongside affiliated investors in Vita Dynamics' Pre-A+++ funding round, with a total capital increase of 300 million yuan. The affiliated investors will contribute 200 million yuan. The deal gives Vita Dynamics a pre-money valuation of 3 billion yuan. After the capital increase, Jiangte Electric and the affiliated investors are expected to hold 3.0303% and 6.0606%, respectively. Jiangte also said it has started joint development of dexterous hand motors and key components with Vita Dynamics, and the products are planned to be supplied to third-party robot OEMs.

  • DeepSeek to lead funding in robotics AI startup Winverse AI

    DeepSeek plans to lead a funding round of tens of millions of dollars in robotics AI company Winverse AI, people familiar with the matter said. Meituan's Longzhu Capital and others have also committed, valuing Winverse at about $400 million (2.7 billion yuan). The deal is not final and details could change. If completed, it would be one of DeepSeek's largest startup investments since its 2023 founding. DeepSeek previously invested in Unitree Robotics, holding 0.2308%, or 933,399 shares, to co-develop embodied intelligence models. Founded in 2026, Winverse focuses on robot AI models. Founder Hu Han earned a bachelor's degree from Tsinghua in 2008 and a PhD there in 2014. He was previously a Tencent Distinguished Scientist leading Hunyuan vision-language and embodied foundation model teams, and worked at Microsoft Research Asia and Baidu.
MORE

Hot Topics

RobotHOT - China & Global Robotics Insights

RobotHOT brings China & Global Robotics Insights. Explore robotics, embodied‑intelligence updates, startup news and industry analysis for professionals worldwide.

About USContact US